We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Sample Management System Is Combined with Lab Analyses

By Labmedica staff writers
Posted on 16 Jul 2008
Print article
A sample management system has been developed that can be combined with analysis systems for immunology and clinical chemistry.

VersaCell Combo, developed by Siemens Healthcare (Erlangen, Germany), is a cost-effective solution for the combination of immunology diagnostics and clinical chemistry. The sample management system combines Siemens' Immulite 2000 or Immulite 2500 analysis systems with the Advia 1800, the analysis system for clinical chemistry. The throughput of the individual modules is identical with that of the stand-alone systems. If one of the modules fails, the other system can continue with sample processing without interruption of operations.

The system accommodates up to 200 sample tubes, identifies the tests and the patient, and feeds the relevant samples to the corresponding analysis system. Technologists do not have to manually sort the tubes or forward them from one system to the next if samples have to be tested for various analytes. VersaCell Combo enables efficient processing and allows the automation of processes in the lab.

The requested assays are detected using patient barcodes on the tubes and direct communication with the lab information system (LIS) and the samples are automatically fed to the correct module. A robot arm continuously feeds and discharges the samples without interrupting test processing in the two analysis systems. Emergency samples can be analyzed quickly and without delay, by directly applying up to 79 different methods. VersaCell Combo monitors the status of the connected analysis systems, as well as the on-board reagent supply and generates an alarm signal if reagents need to be replaced.

The system was designed for large and medium-sized labs. A comprehensive test menu combines more than 180 assays for routine, protein, medication, and drug analysis in clinical chemistry with the spectrum of immunology diagnostics including the fields of fertility, thyroid gland, and tumor markers.


Related Links:
Siemens
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
New
Fixed Volume Pipettor
Labpette FX

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The MCED test can screen for up to 42 solid tumors and five hematological tumors (Photo courtesy of 123RF)

Non-Invasive Test Detects Up To 42 Solid Tumors and Five Blood Cancers in Blood and Urine Samples

Cancer is now responsible for nearly 1 in 6 deaths worldwide. Each year, over 14 million people are diagnosed with cancer, and this number is expected to surpass 21 million by 2030. A major issue is that... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The new assays will run on the QIAcuity digital PCR (dPCR) platform (Photo courtesy of QIAGEN)

New Digital PCR Assays Enable Accurate and Sensitive Detection of Critical Pathogens

QIAGEN (Venlo, the Netherlands) has introduced 100 new assays for its QIAcuity digital PCR (dPCR) platform, aimed at advancing research in areas such as cancer, inherited genetic disorders, and infectious... Read more

Pathology

view channel
Image: The new AI technology more precisely predicts the risk of getting breast cancer (Photo courtesy of William Brøns Petersen)

AI Technology Accurately Predicts Breast Cancer Risk Via ‘Zombie Cells’

Breast cancer remains one of the most common cancers worldwide, causing 670,000 deaths in 2022. A key aspect of assessing cancer risk involves identifying dying cells. A new study has demonstrated that... Read more

Industry

view channel
Image: International expert meeting for trends and innovations in laboratory medicine - the MEDICA LABMED FORUM at MEDICA (Photo courtesy of Constanze Tillmann/Messe Düsseldorf)

MEDICA LABMED FORUM 2024: International Experts Meet to Discuss Trending Topics in Laboratory Medicine

At MEDICA (Düsseldorf, Germany), the world’s premier trade fair for the healthcare industry and medical technology sector, this year’s event (November 11–14) will focus on the most exciting medical advancements.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.